-
561“…Hepatitis C virus screening was conducted among 8,226 residents 25–65 years of age in 4 counties of China; virus prevalence was 0.9%. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
562por Romano, Camila Malta, de Carvalho-Mello, Isabel M. V. Guedes, Jamal, Leda F., de Melo, Fernando Lucas, Iamarino, Atila, Motoki, Marco, Pinho, João Renato Rebello, Holmes, Edward C., Zanotto, Paolo Marinho de Andrade“…Hepatitis C virus (HCV) infects 170 million people worldwide, and is a major public health problem in Brazil, where over 1% of the population may be infected and where multiple viral genotypes co-circulate. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
563“…Dysfunction of the virus-specific T cells is a cardinal feature in chronic persistent viral infections such as one caused by hepatitis C virus (HCV). In chronic HCV infection, virus-specific dysfunctional CD8 T cells often overexpress various inhibitory receptors. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
564“…Interferons were first described in 1957, but it was not until 34 years after their discovery that sufficient quantities of it were available for treatment of hepatitis C virus (HCV) infections, Clinicians now have an excellent understanding of the basis for the effectiveness of interferon alpha (IFN-α) in the therapy of this disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
565
-
566
-
567
-
568
-
569“…To estimate the prevalence of hepatitis C virus (HCV) infection among Korean adults and to present the putative route of HCV transmission among them, serum samples from 4917 adults older than 20 years of age were tested for antibody to HCV (anti-HCV), and histories of blood transfusion and other pertinent information were obtained by self-administered questionnaires. …”
Enlace del recurso
Enlace del recurso
Texto -
570
-
571por Senevirathna, Dammika, Amuduwage, Senani, Weerasingam, Shirani, Jayasinghe, Saroj, Fernandopulle, Neil“…INTRODUCTION: Hepatitis C virus (HCV) is the etiological agent for the majority of cases of non-A, non-B hepatitis. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
572por Tavis, John E, Donlin, Maureen J, Aurora, Rajeev, Fan, Xiaofeng, Di Bisceglie, Adrian M“…Chronic hepatitis C virus (HCV) infection is a major cause of liver disease worldwide. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
573por Tang, Ignatius Y. S., Walzer, Natasha, Aggarwal, Nidhi, Tzvetanov, Ivo, Cotler, Scott, Benedetti, Enrico“…Chronic Hepatitis C (HCV) infection is an important cause of morbidity and mortality in patients with end-stage renal disease. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
574por Hagr, Abdulrahman, Jamjoom, Dima, Sanai, Faisal M., Al Hamoudi, Waleed, Abdo, Ayman A., Al-Arfaj, Ahmed“…BACKGROUND/AIM: Some reports in the literature have linked interferon therapy for the treatment of hepatitis C (HCV) with hearing loss. The aim of this study has been to examine the effects of interferon therapy on hearing of patients treated for HCV. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
575por Coffin, Phillip O, Stevens, Anne M, Scott, John D, Stekler, Joanne D, Golden, Matthew R“…BACKGROUND: In the United States, about 70% of 2.9-3.7 million people with hepatitis C (HCV) are unaware of their infection. Although universal screening might be a cost-effective way to identify infections, prevent morbidity, and reduce transmission, few efforts have been made to determine patient opinions about new approaches to screening. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
576por Shavakhi, Ahmad, Norinayer, Babak, Esteghamat, Fateme Sadat, Seghatoleslami, Mohamad, Khodadustan, Mahsa, Somi, Mohamad Hosein, Masoodi, Mohsen, Zali, Mohamad Reza“…The aim of this study is to determine frequency of occult hepatitis B among hepatitis C patients in Tehran and compare the route of transmission and liver enzymes between positive and negative HBV DNA patients. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
577por Ijaz, Bushra, Ahmad, Waqar, Javed, Fouzia T, Gull, Sana, Sarwar, Muhammad T, Kausar, Humera, Asad, Sultan, Jahan, Shah, Khaliq, Saba, Shahid, Imran, Sumrin, Aleena, Hassan, Sajida“…Relationship between ALP and bilirubin with viral load may be an attractive marker to guess disease progression in patients with hepatitis C.…”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
578por Wang, Jane H, Pianko, Matthew J, Ke, Xiaogang, Herskovic, Alex, Hershow, Ronald, Cotler, Scott J, Chen, Weijin, Chen, Zheng W, Rong, Lijun“…RESULTS: Using sythetic peptides of a HLA-DRB1*15-restricted CD4 epitope derived from the non-structural (NS) 3 protein of hepatitis C virus (HCV) and its antigenic variants and the peripheral blood mononuclear cells (PBMC) from six HLA-DRB1*15-positive patients chronically infected with HCV and 3 healthy subjects, the in vitro immune responses and the phenotypes of CD4(+)CD25(+ )cells of chronic HCV infection were investigated. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
579“…BACKGROUND AND AIM: Phylogenetic analysis has led to the classification of hepatitis C virus (HCV) into 1-6 major genotypes. HCV genotypes have different biological properties, clinical outcome and response to antiviral treatment and provide important clues for studying the epidemiology, transmission and pathogenesis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
580“…Hepatitis C virus (HCV) represents a major health burden, with an estimated 180 million chronically infected individuals worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto